193 related articles for article (PubMed ID: 34939086)
1. N-acetyl-β-D-hexosaminidases mediate the generation of paucimannosidic proteins via a putative noncanonical truncation pathway in human neutrophils.
Ugonotti J; Kawahara R; Loke I; Zhu Y; Chatterjee S; Tjondro HC; Sumer-Bayraktar Z; Neelamegham S; Thaysen-Andersen M
Glycobiology; 2022 Mar; 32(3):218-229. PubMed ID: 34939086
[TBL] [Abstract][Full Text] [Related]
2. Human neutrophils secrete bioactive paucimannosidic proteins from azurophilic granules into pathogen-infected sputum.
Thaysen-Andersen M; Venkatakrishnan V; Loke I; Laurini C; Diestel S; Parker BL; Packer NH
J Biol Chem; 2015 Apr; 290(14):8789-802. PubMed ID: 25645918
[TBL] [Abstract][Full Text] [Related]
3. I. Abnormalities in cells of the testis, efferent ducts, and epididymis in juvenile and adult mice with beta-hexosaminidase A and B deficiency.
Adamali HI; Somani IH; Huang JQ; Mahuran D; Gravel RA; Trasler JM; Hermo L
J Androl; 1999; 20(6):779-802. PubMed ID: 10591618
[TBL] [Abstract][Full Text] [Related]
4. Promoters for the human beta-hexosaminidase genes, HEXA and HEXB.
Norflus F; Yamanaka S; Proia RL
DNA Cell Biol; 1996 Feb; 15(2):89-97. PubMed ID: 8634145
[TBL] [Abstract][Full Text] [Related]
5. Human protein paucimannosylation: cues from the eukaryotic kingdoms.
Tjondro HC; Loke I; Chatterjee S; Thaysen-Andersen M
Biol Rev Camb Philos Soc; 2019 Dec; 94(6):2068-2100. PubMed ID: 31410980
[TBL] [Abstract][Full Text] [Related]
6. Structure and expression of the mouse beta-hexosaminidase genes, Hexa and Hexb.
Yamanaka S; Johnson ON; Norflus F; Boles DJ; Proia RL
Genomics; 1994 Jun; 21(3):588-96. PubMed ID: 7959736
[TBL] [Abstract][Full Text] [Related]
7. Development of infertility at young adult age in a mouse model of human Sandhoff disease.
Juneja SC
Reprod Fertil Dev; 2002; 14(7-8):407-12. PubMed ID: 12617783
[TBL] [Abstract][Full Text] [Related]
8. Distribution of enzyme-bearing cells in GM2 gangliosidosis mice: regionally specific pattern of cellular infiltration following bone marrow transplantation.
Oya Y; Proia RL; Norflus F; Tifft CJ; Langaman C; Suzuki K
Acta Neuropathol; 2000 Feb; 99(2):161-8. PubMed ID: 10672323
[TBL] [Abstract][Full Text] [Related]
9. Conversion of brain-specific complex type sugar chains by N-acetyl-beta-D-hexosaminidase B.
Okamoto Y; Omichi K; Yamanaka S; Ikenaka K; Hase S
J Biochem; 1999 Mar; 125(3):537-40. PubMed ID: 10050042
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the testis and epididymis in mouse models of human Tay Sachs and Sandhoff diseases and partial determination of accumulated gangliosides.
Trasler J; Saberi F; Somani IH; Adamali HI; Huang JQ; Fortunato SR; Ritter G; Gu M; Aebersold R; Gravel RA; Hermo L
Endocrinology; 1998 Jul; 139(7):3280-8. PubMed ID: 9645704
[TBL] [Abstract][Full Text] [Related]
11. Metabolic correction in microglia derived from Sandhoff disease model mice.
Tsuji D; Kuroki A; Ishibashi Y; Itakura T; Itoh K
J Neurochem; 2005 Sep; 94(6):1631-8. PubMed ID: 16092933
[TBL] [Abstract][Full Text] [Related]
12. Inefficiency in GM2 ganglioside elimination by human lysosomal beta-hexosaminidase beta-subunit gene transfer to fibroblastic cell line derived from Sandhoff disease model mice.
Itakura T; Kuroki A; Ishibashi Y; Tsuji D; Kawashita E; Higashine Y; Sakuraba H; Yamanaka S; Itoh K
Biol Pharm Bull; 2006 Aug; 29(8):1564-9. PubMed ID: 16880605
[TBL] [Abstract][Full Text] [Related]
13. Purification, biochemical properties and active sites of N-acetyl-beta-D-hexosaminidases from human seminal plasma.
Kapur DK; Gupta GS
Biochem J; 1986 May; 236(1):103-9. PubMed ID: 2947567
[TBL] [Abstract][Full Text] [Related]
14. Identification of candidate active site residues in lysosomal beta-hexosaminidase A.
Fernandes MJ; Yew S; Leclerc D; Henrissat B; Vorgias CE; Gravel RA; Hechtman P; Kaplan F
J Biol Chem; 1997 Jan; 272(2):814-20. PubMed ID: 8995368
[TBL] [Abstract][Full Text] [Related]
15. Changes in serum N-acetyl-beta-hexosaminidase levels after treatment of hypothyroid and hyperthyroid individuals with L-thyroxine and propylthiouracil.
Oberkotter LV; Tenore A; Koldovsky O
Clin Chim Acta; 1980 Nov; 108(1):61-6. PubMed ID: 6450007
[TBL] [Abstract][Full Text] [Related]
16. Active arginine residues in beta-hexosaminidase. Identification through studies of the B1 variant of Tay-Sachs disease.
Brown CA; Mahuran DJ
J Biol Chem; 1991 Aug; 266(24):15855-62. PubMed ID: 1831451
[TBL] [Abstract][Full Text] [Related]
17. Common HEXB polymorphisms reduce serum HexA and HexB enzymatic activities, potentially masking Tay-Sachs disease carrier identification.
Vallance H; Morris TJ; Coulter-Mackie M; Lim-Steele J; Kaback M
Mol Genet Metab; 2006 Feb; 87(2):122-7. PubMed ID: 16352452
[TBL] [Abstract][Full Text] [Related]
18. Presence of an atypical thermolabile species of beta-hexosaminidase B in metastatic-tumour tissue of human liver.
Alhadeff JA; Holzinger RT
Biochem J; 1982 Jan; 201(1):95-9. PubMed ID: 6211170
[TBL] [Abstract][Full Text] [Related]
19. Structural comparison of hexosaminidases in primates.
Lee JE; Yoshida A; Brandt IK
Comp Biochem Physiol B; 1979; 63(4):491-4. PubMed ID: 162586
[TBL] [Abstract][Full Text] [Related]
20. N-acetyl-beta-hexosaminidase beta locus defect and juvenile motor neuron disease: a case study.
Cashman NR; Antel JP; Hancock LW; Dawson G; Horwitz AL; Johnson WG; Huttenlocher PR; Wollmann RL
Ann Neurol; 1986 Jun; 19(6):568-72. PubMed ID: 3014997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
